Form 8-K - Current report:
SEC Accession No. 0001104659-25-006756
Filing Date
2025-01-28
Accepted
2025-01-28 17:01:35
Documents
13
Period of Report
2025-01-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm254257d1_8k.htm   iXBRL 8-K 26086
  Complete submission text file 0001104659-25-006756.txt   199348

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA asrt-20250122.xsd EX-101.SCH 3021
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20250122_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20250122_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT tm254257d1_8k_htm.xml XML 3678
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 25565326
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)